Rendering of NorthStar Medical Radioisotopes' new site in Beloit, WI.

Ra­dioiso­tope com­pa­ny moves for­ward with CD­MO plans, break­ing ground on new man­u­fac­tur­ing site in Wis­con­sin

As the ra­dio­phar­ma­ceu­ti­cal mar­ket has been at­tract­ing a healthy amount of at­ten­tion and cap­i­tal, one com­pa­ny is look­ing to plant its flag in the pro­duc­tion of ra­dioiso­topes for use in ther­a­peu­tics.

North­Star Med­ical Ra­dioiso­topes, a Wis­con­sin-based ra­dioiso­tope pro­duc­er, is look­ing to build its CD­MO arm with a new pro­duc­tion fa­cil­i­ty to make ra­dio­phar­ma­ceu­ti­cals used to treat can­cer pa­tients.

The new CD­MO wing of the com­pa­ny will aim to pro­vide col­lab­o­ra­tor com­pa­nies with a wider range of de­vel­op­ment and com­mer­cial ser­vices as well as progress its in-house ra­dio­phar­ma­ceu­ti­cal pro­grams.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.